Výsledky vyhledávání - G. Charpentier
- Zobrazuji výsledky 1 - 20 z 52
- Přejít na další stránku
-
1
-
2
Diabeloop DBLG1 Closed-Loop System Enables Patients With Type 1 Diabetes to Significantly Improve Their Glycemic Control in Real-Life Situations Without Serious Adverse Events: 6-M... Autor Coralie Amadou, Sylvia Franc, Pierre‐Yves Benhamou, Sandrine Lablanche, Erik Huneker, G. Charpentier, A. Penfornis
Vydáno 2021Artigo -
3
One‐year real‐world performance of the <scp>DBLG1</scp> closed‐loop system: Data from 3706 adult users with type 1 diabetes in Germany Autor Pierre‐Yves Benhamou, Alice Adenis, Hocine Lebbad, Yousra Tourki, Maria‐Belen Heredia, Bernhard Gehr, Sylvia Franc, G. Charpentier
Vydáno 2023Artigo -
4
Implication of the Pro12Ala polymorphism of the PPAR-gamma 2gene in type 2 diabetes and obesity in the French population Autor Maya Ghoussaini, Stephen Eyre, Stéphane Lobbens, G. Charpentier, Karine Clément, Marie‐Aline Charles, M. Tauber, Jacques Weill, Philippe Froguel
Vydáno 2005Artigo -
5
Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline <scp>BMI</scp> or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials Autor Bo Åhrén, Stephen L. Atkin, G. Charpentier, Mark Warren, John Wilding, Stephen Birch, Anders G. Holst, Lawrence A. Leiter
Vydáno 2018Artigo -
6
The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies Autor Stéphane Cauchi, Kevin T. Nead, Hélène Choquet, Fritz Horber, Natascha Potoczna, Beverley Balkau, Michel Marre, G. Charpentier, Philippe Froguel, David Meyre
Vydáno 2008Artigo -
7
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial Autor Andrew Ahmann, Matthew Capehorn, G. Charpentier, Francesco Dotta, Elena Henkel, Ildiko Lingvay, Anders G. Holst, Miriam Annett, Vanita R. Aroda
Vydáno 2017Artigo -
8
Efficacy of a Hybrid Closed-Loop Solution in Patients With Excessive Time in Hypoglycaemia: A Post Hoc Analysis of Trials With DBLG1 System Autor Pierre‐Yves Benhamou, Alice Adenis, Yousra Tourki, Sylvie Pou, Stéphanie Madrolle, Sylvia Franc, Dulanjalee Kariyawasam, Jacques Beltrand, David C. Klonoff, G. Charpentier
Vydáno 2022Artigo -
9
Genetic Analysis of <i>ADIPOR1</i> and <i>ADIPOR2</i> Candidate Polymorphisms for Type 2 Diabetes in the Caucasian Population Autor Martine Vaxillaire, Aurélie Dechaume, Valérie Vasseur-Delannoy, Saida Lahmidi, Vincent Vatin, Frédéric Leprêtre, Philippe Boutin, Serge Herçberg, G. Charpentier, Christian Dina, Philippe Froguel
Vydáno 2006Artigo -
10
Hospital stays and costs of telemedical monitoring versus standard follow-up for diabetic foot ulcer: an open-label randomised controlled study Autor Dured Dardari, Sylvia Franc, G. Charpentier, L. Orlando, Elise Bobony, Marie Bouly, I. Xhaard, Zohra Amrous, Khadijatou Ly Sall, B. Detournay, A. Penfornis
Vydáno 2023Artigo -
11
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial Autor John Wilding, G. Charpentier, Priscilla Hollander, Guillermo González-Gálvez, Chantal Mathieu, Frank Vercruysse, Keith Usiskin, Ga‐Lai Law, Simon Black, William Canovatchel, Gary Meininger
Vydáno 2013Artigo -
12
Impact of Common Type 2 Diabetes Risk Polymorphisms in the DESIR Prospective Study Autor Martine Vaxillaire, J Veslot, Christian Dina, Christine Proença, Stéphane Cauchi, G. Charpentier, Jean Tichet, Frédéric Fumeron, Michel Marre, David Meyre, Beverley Balkau, Philippe Froguel
Vydáno 2007Artigo -
13
Glycaemic control in type 2 diabetic patients on chronic haemodialysis: use of a continuous glucose monitoring system Autor Jean‐Pierre Riveline, J. Teynié, S. Belmouaz, Sylvia Franc, Dured Dardari, Marc Bauwens, Valérie Caudwell, Stéphanie Ragot, Frank Bridoux, G. Charpentier, R. Maréchaud, Samy Hadjadj
Vydáno 2009Artigo -
14
Ketosis-Prone Type 2 Diabetes in Patients of Sub-Saharan African Origin Autor Franck Mauvais‐Jarvis, Eugène Sobngwi, Raphaël Porcher, Jean‐Pierre Riveline, Jean-Philippe Kévorkian, Christian Vaisse, G. Charpentier, Pierre-Jean Guillausseau, Patrick Vexiau, Jean‐François Gautier
Vydáno 2004Artigo -
15
Quality of Care of People With Type 2 Diabetes in Eight European Countries Autor Margaret Stone, G. Charpentier, Kris Doggen, Oliver Kuß, Ulf Lindblad, Christiane Kellner, John J. Nolan, Agnieszka Pazderska, Guy E.H.M. Rutten, Marina Trento, Kamlesh Khunti
Vydáno 2013Artigo -
16
Insulin Infusion Set Use: European Perspectives and Recommendations Autor Dorothee Deiss, Peter Adolfsson, Marije Alkemade-van Zomeren, Geremia B. Bolli, G. Charpentier, Claudio Cobelli, Thomas Danne, A. Girelli, Heiko Mueller, Carol A. Verderese, Éric Renard
Vydáno 2016Artigo -
17
Insulin‐based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the <scp>DIABRASPORT</scp> randomized study Autor Sylvia Franc, A. Daoudi, A. Pochat, M. Petit, Caroline Randazzo, C. Petit, Martine Duclos, A. Penfornis, Eric Pussard, D. Not, Elsa Heyman, François Koukoui, Chantal Simon, G. Charpentier
Vydáno 2015Artigo -
18
The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients Autor G. Charpentier, Pierre‐Yves Benhamou, Dured Dardari, Annie Clergeot, Sylvia Franc, P Schaepelynck-Bélicar, Bogdan Catargi, V. Melki, Lucy Chaillous, Anne Farret, Jean‐Luc Bosson, A. Penfornis
Vydáno 2011Artigo -
19
Transcription Factor <i>TCF7L2</i> Genetic Study in the French Population Autor Stéphane Cauchi, Stephen Eyre, Christian Dina, Hélène Choquet, Chantal Samson, Sophie Gallina, Beverley Balkau, G. Charpentier, François Pattou, Volodymyr Stetsyuk, Raphaël Scharfmann, Bart Staels, Gema Frühbeck, Philippe Froguel
Vydáno 2006Artigo -
20
Hybrid closed-loop insulin delivery versus sensor-augmented pump therapy in children aged 6–12 years: a randomised, controlled, cross-over, non-inferiority trial Autor Dulanjalee Kariyawasam, Carole Morin, Kristina Casteels, C. Le Tallec, Annie Sfez, Cécile Godot, Erik Huneker, Nathalie Garrec, Pierre‐Yves Benhamou, Michel Polak, G. Charpentier, Sylvia Franc, Jacques Beltrand
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Endocrinology
Diabetes mellitus
Type 2 diabetes
Biology
Gene
Genetics
Genotype
Single-nucleotide polymorphism
Insulin
Genome-wide association study
Allele
Environmental health
Obesity
Population
Type 1 diabetes
Insulin resistance
Genetic association
Odds ratio
Randomized controlled trial
Glucose homeostasis
Receptor
TCF7L2
Alternative medicine
Bioinformatics
Computational biology
Pathology
Placebo
Gastroenterology